Events

Interventions for managing ADHD include medications, such as stimulants (methylphenidate and amphetamines) and non-stimulants (eg, atomoxetine, bupropion, clonidine, guanfacine, and viloxazine), as well as non-pharmacological approaches such as behavioural therapies, dietary interventions, and neurofeedback. Current guidelines generally recommend medication—typically stimulants as first-line treatment and non-stimulants as second-line—combined with behavioural or cognitive behavioural therapies. Although many meta-analyses of randomised controlled trials have assessed ADHD treatments, their usefulness for clinicians is limited. They often focus on narrow outcomes, show conflicting results for the same interventions, and frequently do not assess evidence quality. Additionally, findings are mainly published in academic journals, limiting accessibility for people with ADHD, who have called for clearer, evidence-based online resources.

A community health fair dedicated to reducing HIV/AIDs stigma and increasing access to care through health education, community dialogue, and connection. Presented in collaboration with Boston Public Health Commission, Myrtle Baptist Church, and Multicultural AIDS Coalition.